BQ0413

Technetium-99m labeled PSMA-targeted radiopharmaceutical · Tomsk National Research Medical Center of the Russian Academy of Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BQ0413, covering 2025-04-09 to 2025-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413 [Phase 1]